Evidence for p53 as guardian of the cardiomyocyte mitochondrial genome following acute adriamycin treatment

Ramaneeya Nithipongvanitch, Wanida Ittarat, Joyce M. Velez, Rui Zhao, Daret K. St. Clair, Terry D. Oberley

Research output: Contribution to journalArticlepeer-review

70 Scopus citations


The present study is an initial analysis of whether p53 may function as guardian of the cardiomyocyte mitochondrial genome, with mitochondrial p53 localization proposed to be involved in both mitochondrial DNA (mtDNA) repair and apoptosis. Subcellular distribution, protein levels, and possible function(s) of p53 protein in the response of cardiomyocytes to adriamycin (ADR) were analyzed. Levels and subcellular localization of proteins were determined by Western blot and immunogold ultrastructural analysis techniques. Here we demonstrate that stress caused by ADR induced upregulation of p53 protein in cardiomyocyte mitochondria and nuclei between 3 and 24 hr. Increased expression of PUMA and Bax proteins, pro-apoptotic targets of p53, was documented following ADR treatment and was accompanied by increased levels of apoptotic markers, with elevation of cytosolic cytochrome c at 24 hr and subsequent caspase-3 cleavage at 3 days. Mitochondrial p53 levels correlated with mtDNA oxidative damage. Loss of p53 in knockout mouse heart resulted in a significant increase in mtDNA vulnerability to damage following ADR treatment. Our results suggest that mitochondrial p53 could participate in mtDNA repair as a first response to oxidative damage of cardiomyocyte mtDNA and demonstrate an increase of apoptotic markers as a result of mitochondrial/nuclear p53 localization.

Original languageEnglish
Pages (from-to)629-639
Number of pages11
JournalJournal of Histochemistry and Cytochemistry
Issue number6
StatePublished - Jun 2007


  • Apoptosis
  • Cardiomyopathy
  • Doxorubicin
  • Mitochondrial DNA
  • Oxidative stress

ASJC Scopus subject areas

  • Anatomy
  • Histology


Dive into the research topics of 'Evidence for p53 as guardian of the cardiomyocyte mitochondrial genome following acute adriamycin treatment'. Together they form a unique fingerprint.

Cite this